An Investigation of Recurrent Neural Architectures for Drug Name Recognition
Drug name recognition (DNR) is an essential step in the Pharmacovigilance (PV) pipeline. DNR aims to find drug name mentions in unstructured biomedical texts and classify them into predefined categories. State-of-the-art DNR approaches heavily rely on hand crafted features and domain specific resources which are difficult to collect and tune. For this reason, this paper investigates the effectiveness of contemporary recurrent neural architectures - the Elman and Jordan networks and the bidirectional LSTM with CRF decoding - at performing DNR straight from the text. The experimental results achieved on the authoritative SemEval-2013 Task 9.1 benchmarks show that the bidirectional LSTM-CRF ranks closely to highly-dedicated, hand-crafted systems.
Code (1)
Tasks
PharmacovigilanceMethods 이 논문이 사용한 방법론
Similar Papers 제목 키워드 기반
GNTeam at 2018 n2c2: Feature-augmented BiLSTM-CRF for drug-related entity recognition in hospital discharge summaries
Monitoring the administration of drugs and adverse drug reactions are key parts of pharmacovigilance. In this paper, we explore the extraction of drug mentions and drug-related information (reason for taking a drug, rout…
Entity Extraction using GANnamed-entity-recognitionNamed Entity RecognitionNamed Entity Recognition (NER)+2Mamba-360: Survey of State Space Models as Transformer Alternative for Long Sequence Modelling: Methods, Applications, and Challenges
Sequence modeling is a crucial area across various domains, including Natural Language Processing (NLP), speech recognition, time series forecasting, music generation, and bioinformatics. Recurrent Neural Networks (RNNs)…
Drug DesignInductive BiasMachine TranslationMamba+12Terminologies augmented recurrent neural network model for clinical named entity recognition
We aimed to enhance the performance of a supervised model for clinical named-entity recognition (NER) using medical terminologies. In order to evaluate our system in French, we built a corpus for 5 types of clinical enti…
Diagnosticnamed-entity-recognitionNamed Entity RecognitionNamed Entity Recognition (NER)+1Unified Neural Architecture for Drug, Disease and Clinical Entity Recognition
Most existing methods for biomedical entity recognition task rely on explicit feature engineering where many features either are specific to a particular task or depends on output of other existing NLP tools. Neural arch…
Feature Engineeringnamed-entity-recognitionNamed Entity RecognitionNamed Entity Recognition (NER)+2A New Data Representation Based on Training Data Characteristics to Extract Drug Named-Entity in Medical Text
One essential task in information extraction from the medical corpus is drug name recognition. Compared with text sources come from other domains, the medical text is special and has unique characteristics. In addition, …
DenoisingSentence